Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Clin Rheumatol. 2016 Aug 29;35(10):2603–2607. doi: 10.1007/s10067-016-3396-5

Table 2.

Multivariate risk factor analysis for cancer incidence in 217 patients with psoriatic arthritis (PsA)

N (%) or Hazard ratio
Characteristic mean (SD) (95% CI) P value
Age, per 1 year increase 44.0 (±14,2) 1.08 (1.05, 1.11) <0.001
Female sex 86 (40%) 2.17 (1.05, 4.48) 0.037
Calendar year of PsA incidence 1994 (± 9) 0.98 (0.94, 1.02) 0.320
Inflammatory joint pain present 190 (88%) 0.85 (0.19, 3.77) 0.829
Enthesitis PsA 74 (34%) 1.10 (0.46, 2.60) 0.830
Spine PsA 17 (8%) 1.35 (0.31, 5.80) 0.687
Family history of psoriasis 52/123 (42%) 0.92 (0.25, 3.40) 0.901
Psoriatic nail dystrophy 88 (41%) 0.52 (0.22, 1.24) 0.142
Negative rheumatoid factor 178/182 (98%) -- 0.991
Dactylitis 102 (47%) 0.66 (0.31, 1.39) 0.270